Dose-Finding Designs for Early-Phase Cancer Clinical Trials
Kurzinformation
inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
This book provides a comprehensive introduction to statistical methods for designing early phase dose-finding clinical trials. It will serve as a textbook or handbook for graduate students and practitioners in biostatistics and clinical investigators who are involved in designing, conducting, monitoring, and analyzing dose-finding trials. The book will also provide an overview of advanced topics and discussions in this field for the benefit of researchers in biostatistics and statistical science. Beginning with backgrounds and fundamental notions on dose finding in early phase clinical trials, the book then provides traditional and recent dose-finding designs of phase I trials for, e.g., cytotoxic agents in oncology, to evaluate toxicity outcome. Included are rule-based and model-based designs, such as 3 + 3 designs, accelerated titration designs, toxicity probability interval designs, continual reassessment method and related designs, and escalation overdose control designs. This book also covers more complex and updated dose-finding designs of phase I-II and I/II trials for cytotoxic agents, and cytostatic agents, focusing on both toxicity and efficacy outcomes, such as designs with covariates and drug combinations, maximum tolerated dose-schedule finding designs, and so on. von Daimon, Takashi
Produktdetails
So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
Takashi Daimon, Department of Biostatistics, Hyogo College of MedicineAkihiro Hirakawa, Center for Advanced Medicine and Clinical Research, Nagoya University Graduate School of MedicineShigeyuki Matsui, Department of Biostatistics, Nagoya University Graduate School of Medicine
- Hardcover
- 480 Seiten
- Erschienen 2014
- John Wiley & Sons Inc
- Gebunden
- 928 Seiten
- Erschienen 2017
- Wiley & Sons
- Gebunden
- 766 Seiten
- Erschienen 2018
- Wiley-VCH
- hardcover
- 374 Seiten
- Erschienen 2011
- Springer
- paperback
- 408 Seiten
- Erschienen 2012
- Springer
- hardcover
- 2659 Seiten
- Erschienen 2022
- Springer
- hardcover
- 1822 Seiten
- Erschienen 2011
- Wiley-VCH
- Gebunden
- 316 Seiten
- Erschienen 2005
- Birkhäuser
- hardcover
- 606 Seiten
- Erschienen 2006
- Wiley-VCH
- Hardcover
- 164 Seiten
- Erschienen 2022
- Springer International Publ...
- Hardcover
- 656 Seiten
- Houghton Mifflin Company
- Gebunden
- 452 Seiten
- Erschienen 2018
- Wiley-VCH
- Gebunden
- 300 Seiten
- Erschienen 2021
- Wiley-VCH
- hardcover
- 800 Seiten
- Erschienen 2001
- American Cancer Society
- Gebunden
- 386 Seiten
- Erschienen 2012
- Wiley-VCH




